Changes in serum levels of fibroblast growth factor-2,
hypoxia-inducible factor-1alpha and vascular endothelial growth factor in
patients with avascular necrosis of femoral head treated by enriched autologous
bone marrow stem cell transplantation combined with core decompression

doi:10.3969/j.issn.2095-4344.2002

Abstract

Abstract:

BACKGROUND: Avascular necrosis of the femoral head is mainly caused by insufficient blood supply of the femoral head. Core decompression is a common clinical treatment, enriched autologous bone marrow stem cell transplantation can improve hip function, and combined application can promote early recovery of patients.

OBJECTIVE: To investigate the therapeutic effects of enriched autologous bone marrow stem cell transplantation combined with core decompression on serum levels of fibroblast growth factor-2, hypoxia-inducible factor-1α and vascular endothelial growth factor in patients with early avascular necrosis of femoral head.

METHODS: Sixty-two cases of early avascular necrosis of femoral head treated from January 2016 to January 2018 were selected, and were divided into study group (n=31) and control group (n=31) according to the random number table method. The control group was treated with fine-needle porous-channel core pulp decompression, while the study group was treated with enriched autologous bone marrow stem cell transplantation on the basis of the control group. Harris score, Visual Analogue Scale score, serum fibroblast growth factor-2, hypoxia-inducible factor-1α and vascular endothelial growth factor levels and adverse reactions were observed before and after treatment.

RESULTS AND CONCLUSION: (1) The Harris scores at 3, 6 and 12 months after treatment in the two groups were higher than those before treatment (P < 0.05), and those in the study group were higher than those in the control group (P < 0.05). (2) The Visual Analogue Scale scores at 3, 6 and 12 months after treatment in the two groups were lower than those before treatment (P < 0.05), and the scores at 3 and 6 months after treatment in the study group were lower than those in the control group (P < 0.05). (3) The levels of serum fibroblast growth factor-2 at 3, 6 and 12 months in the two groups were higher than those before treatment, and the scores in the study group were higher than those in the control group (P < 0.05). The levels of hypoxia-inducible factor-1α and vascular endothelial growth factor in the two groups were significantly lower than those before treatment (P < 0.05), and those in the study group were lower than those in the control group (P < 0.05). (4) There was no significant difference in the incidence of adverse reactions between two groups after treatment (P > 0.05). (5) These results suggest that enriched autologous bone marrow stem cell transplantation combined with core decompression in the treatment of early avascular necrosis of femoral head can effectively improve hip joint function, promote the repair of femoral head necrosis area, alleviate pain, increase the level of fibroblast growth factor-2, and reduce the levels of hypoxia-inducible factor-1α and vascular endothelial growth factor.

Key words: avascular necrosis of femoral head, stem cell transplantation, core decompression, fibroblast growth factor-2, hypoxia-inducible factor-1α, vascular endothelial growth factor

CLC Number:

Zhang Jingyi, Hai Guodong, Yang Haofei, Fan Congliang, Yan Lei, Zhang Chunlei, Dou Junfeng, Ma Hailong. Changes in serum levels of fibroblast growth factor-2, hypoxia-inducible factor-1alpha and vascular endothelial growth factor in patients with avascular necrosis of femoral head treated by enriched autologous bone marrow stem cell transplantation combined with core decompression[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(1): 14-14.

Figures/Tables 12

References

[1]GUERADO E, CASO E. The physiopathology of avascular necrosis of the femoral head: an update. Injury. 2016;47 Suppl 6: S16-S26.

[2]NARAYANAN A, KHANCHANDANI P, BORKAR RM, et al. Avascular Necrosis of Femoral Head: A Metabolomic, Biophysical, Biochemical, Electron Microscopic and Histopathological Characterization. Sci Rep. 2017;7(1):10721.

[3]PYDA M, KOCZY B, WIDUCHOWSKI W, et al. Hip resurfacing arthroplasty in treatment of avascular necrosis of the femoral head. Med Sci Monit. 2015;21:304-309.

[4]常再平,王林,李龙,等.髋关节置换术对股骨头坏死患者髋关节Harris评分及运动功能的影响[J].现代生物医学进展,2017,17(11): 2116-2118.

[5]LI X, XU X, WU W. Comparison of bone marrow mesenchymal stem cells and core decompression in treatment of osteonecrosis of the femoral head: a meta-analysis. Int J Clin Exp Pathol. 2014; 7(8):5024-5030.

[6]王得胜,侯毅,刘腾,等.超选择血管介入联合髓芯减压植骨术治疗早中期股骨头缺血性坏死的效果观察[J].中华实用诊断与治疗杂志, 2019, 33(1): 35-36.

[7]朱孟国,张玉梅,王厚义,等.自拟骨愈方联合急诊手术对跟骨SandersⅡ～Ⅲ型闭合骨折HIF-1α及VEGF表达的影响[J].中国中医急症, 2018,27(2):230-232.

[8]仝晓阳,李慧,张苗,等.VEGF和EGFL在骨血管生成中的作用[J].中国细胞生物学学报, 2017, 39(11):1461-1464.

[9]章坚林,于博,刘柱同.胫骨骨折髓内钉固定围术期血清FGF-2和IGF-1水平联合预测其术后骨不连的价值[J].广东医学,2018, 39(1): 122-125.

[10]张晓军,刘健,万磊,等.佐剂关节炎大鼠滑膜组织HIF-1α和VEGF及CD34表达上调促进血管新生[J].细胞与分子免疫学杂志,2015, 31(8):1053-1056.

[11]KURODA Y, ASADA R, SO K, et al. A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head. Int Orthop. 2016;40(8):1747-1754.

[12]李子荣.股骨头坏死临床诊疗规范[J].中华骨与关节外科杂志, 2015, 24(1):97-100.

[13]HARRIS WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51(4):737-755.

[14]严广斌. 视觉模拟评分法[J].中华关节外科杂志(电子版), 2014, 8(2): 125-128.

[15]LIAO Y, SU R, ZHANG P, et al. Cortisol inhibits mTOR signaling in avascular necrosis of the femoral head. J Orthop Surg Res. 2017; 12(1):154.

[16]MONT MA, CHERIAN JJ, SIERRA RJ, et al. Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A Ten-Year Update. J Bone Joint Surg Am.2015;97(19): 1604-1627.

[17]余燕娜,汤水福.中医辨证预防肾病综合征患者激素性股骨头坏死的回顾性分析[J].中国中西医结合肾病杂志, 2017,18(10):910-911.

[18]LANDGRAEBER S, TRAN TN, CLAßEN T, et al. Geometric analysis of an expandable reamer for treatment of avascular necrosis of the femoral head. Arch Orthop Trauma Surg. 2015; 135(10):1357-1362.

[19]余振阳,蔡谞,谷旺.改良多孔道髓芯减压术与传统钻孔减压术治疗早期股骨头缺血坏死的疗效观察[J].解放军医学院学报, 2016, 37(11): 1148-1151.

[20]石卫青,付阳阳,邱依辉,等.多孔道细针髓芯减压预防性治疗0期股骨头坏死的手术配合[J].军事医学, 2016, 40(11):936-936.

[21]杨宾宾,刘耀升,刘蜀彬,等.多种髓芯减压术治疗股骨头坏死的有限元研究[J].中华损伤与修复杂志(电子版), 2017, 12(1):39-45.

[22]李冀,李众利,苏祥正,等.小直径多孔道髓芯减压联合髋关节镜清理治疗早期股骨头缺血性坏死的疗效观察[J].中国修复重建外科杂志, 2017,31(9): 1025-1030.

[23]王秀利,王义生,吴学建,等.自体骨髓干细胞种植骨诱导活性材料移植联合髓芯减压术治疗早期股骨头坏死[J].中华显微外科杂志, 2017,40(2): 142-145.

[24]DALTRO G, FRANCO BA, FALEIRO TB, et al. Use of autologous bone marrow stem cell implantation for osteonecrosis of the knee in sickle cell disease: a preliminary report. BMC Musculoskelet Disord. 2018; 19(1):158.

[25]HEO SH, PARK YS, KANG ES, et al. Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger's Disease. Sci Rep. 2016;6:19690.

[26]YUAN HF, ZHANG J, GUO CA, et al. Clinical outcomes of osteonecrosis of the femoral head after autologous bone marrow stem cell implantation: a meta-analysis of seven case-control studies. Clinics (Sao Paulo). 2016;71(2):110-113.

[27]赵日光,刘宏滨,韩冰,等.髓芯减压联合自体骨髓干细胞移植治疗早期股骨头缺血性坏死的疗效观察[J].人民军医,2016,59(4):372-373.

[28]KANG JS, SUH YJ, MOON KH, et al. Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a matched pair control study with simple core decompression. Stem Cell Res Ther. 2018;9(1):274.

[29]张洋,王楠,杨立枫,等.骨髓间充质干细胞移植联合髓芯减压植骨修复股骨头坏死[J].中国组织工程研究,2015,19(6):883-890.

[30]AWAN B, TURKOV D, SCHUMACHER C, et al. FGF2 Induces Migration of Human Bone Marrow Stromal Cells by Increasing Core Fucosylations on N-Glycans of Integrins. Stem Cell Reports. 2018;11(2):325-333.

[31]YOON KA, SON Y, CHOI YJ, et al. Fibroblast growth factor 2 supports osteoblastic niche cells during hematopoietic homeostasis recovery after bone marrow suppression. Cell Commun Signal. 2017;15(1):25.

[32]HUANG G, ZHAO G, XIA J, et al. FGF2 and FAM201A affect the development of osteonecrosis of the femoral head after femoral neck fracture. Gene. 2018;652:39-47.

[33]PRIETO-DOMÍNGUEZ N, MÉNDEZ-BLANCO C, CARBAJO- PESCADOR S, et al. Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/ HIF-1α and hypoxia-mediated mitophagy. Oncotarget. 2017; 8(53):91402-91414.

[34]XIAO B, WANG S, YANG G, et al. HIF-1α contributes to hypoxia adaptation of the naked mole rat. Oncotarget. 2017;8(66): 109941-109951.

[35]ZHANG W, YUAN Z, PEI X, et al. In vivo and in vitro characteristic of HIF-1α and relative genes in ischemic femoral head necrosis. Int J Clin Exp Pathol. 2015;8(6):7210-7216.

[36]PALAZON A, TYRAKIS PA, MACIAS D, et al. An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression. Cancer Cell. 2017;32(5):669-683.

[37]王秀芳,王莉,张艳丽,等.哮喘患儿血清mTOR、HIF-1α及VEGF的表达及意义[J].中国妇幼保健, 2017,32(6):1197-1199.

[38]牟青杰,赵月华,程丹丹,等.骨髓间充质干细胞移植对氧诱导视网膜病变新生大鼠视网膜新生血管的影响[J].中国当代儿科杂志, 2017, 19(11): 1202-1207.

[39]乔军杰,周萌,黄江,等.低氧诱导因子-1α促进骨折愈合机制的研究进展[J].北京医学, 2018, 40(2):141-143.

谢求恩,张雄,徐永贵.阳和汤对膝关节骨性关节炎患者血清及滑液中HIF-1α和VEGF表达的影响研究[J].环球中医药,2018, 11(3):458-461.